Literature DB >> 8248559

Comparison of treatment techniques for lung cancer.

J F Valley1, R O Mirimanoff.   

Abstract

A comparison of the treatment techniques for a typical case of lung cancer has been performed between 10 Swiss radiation oncology centers. The description and basic imaging data of a locally advanced non-metastatic lung cancer were sent to each institution and participants were asked to perform the treatment planning as for a routine case. The comparison shows that, in addition to a broad spectrum of treatment techniques, there was a significant variation in the major treatment parameters: definition of the target volume, prescription procedure, total dose to the tumor and dose per fraction. Although some reasons could be found to partially explain these differences, the lessons learned from this comparison are, first, that a standardization, in particular for dose prescription, is urgently needed, and, second, that a search for a better consensus in standard managements should be promoted in radiation oncology.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8248559     DOI: 10.1016/0167-8140(93)90010-6

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  2 in total

1.  Conformal radiotherapy for lung cancer: interobservers' variability in the definition of gross tumor volume between radiologists and radiotherapists.

Authors:  Chiang J Tyng; Rubens Chojniak; Paula N V Pinto; Marcelle A Borba; Almir G V Bitencourt; Ricardo C Fogaroli; Douglas G Castro; Paulo E Novaes
Journal:  Radiat Oncol       Date:  2009-08-05       Impact factor: 3.481

2.  Impact of Interobserver Variability in Manual Segmentation of Non-Small Cell Lung Cancer (NSCLC) Applying Low-Rank Radiomic Representation on Computed Tomography.

Authors:  Michelle Hershman; Bardia Yousefi; Lacey Serletti; Maya Galperin-Aizenberg; Leonid Roshkovan; José Marcio Luna; Jeffrey C Thompson; Charu Aggarwal; Erica L Carpenter; Despina Kontos; Sharyn I Katz
Journal:  Cancers (Basel)       Date:  2021-11-28       Impact factor: 6.575

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.